Physician profile
David Spengler
NPI 1225624448
$5,293.38
in general payments reported to CMS, 2019-2025
14 companies · $1,153 in 2025
The $1,153 reported for 2025 was more than what 93% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $108 · 2022: $234 · 2023: $920 · 2024: $2,879 · 2025: $1,153.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,065 · Travel and Lodging: $887.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,065.20 |
| Travel and Lodging | $886.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb Americas INC. | $3,079.92 | 2023-2025 | Infuse, Xiidra, Miebo |
| Biotissue Holdings INC. | $309.26 | 2024-2025 | |
| Coopervision INC. | $305.43 | 2022-2025 | Clariti Contact Lens, Myday Contact Lens |
| Lumenis Be INC | $292.27 | 2025 | Optilight |
| Sight Sciences, INC. | $266.91 | 2023 | Omni Surgical System, Tearcare System |
| Amgen INC. | $246.25 | 2024 | Tepezza |
| Alcon Vision LLC | $167.37 | 2024-2025 | Eysuvis, Precision7 |
| Reichert, INC. | $140.80 | 2022 | |
| Harrow Eye, LLC | $121.03 | 2025 | Vevye |
| Horizon Therapeutics Plc | $112.94 | 2023 | Tepezza |
| Johnson & Johnson Vision Care, INC. | $107.68 | 2021 | |
| Sun Pharmaceutical Industries INC. | $83.25 | 2025 | |
| Rayner Intraocular Lenses Limited | $39.13 | 2024 | Rayone Spheric, Rayone Aspheric, Rayone Emv |
| Rxsight INC | $21.14 | 2023 | Rxsight Injector Cartridge, Rxsight Contact Lens, Rxsight Light Delivery Device (Ldd) |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Spengler listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.